Prevalence of measles antibodies in adults with HIV infection: possible risk factors of measles seronegativity. NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Prevalence of measles antibodies in adults with HIV infection: possible risk factors of measles seronegativity.

AIDS. 1992 Nov;6(11):1321-5. Unique Identifier : AIDSLINE MED/93112305
Kemper CA; Zolopa AR; Hamilton JR; Fenstersheib M; Bhatia G; Deresinski SC; Department of Medicine, Stanford University School of Medicine,; California.


Abstract: OBJECTIVES: To determine the prevalence of measles (rubeola) immunity in a group of HIV-1-infected adults and to examine predictors of measles seronegativity in this population. SETTING: County hospital outpatient clinic and public-health department early HIV intervention clinic. PATIENTS: A total of 262 HIV-infected adults presenting to outpatient clinics between September 1990 and January 1991. INTERVENTIONS: Patients were screened for the presence of measles immunoglobulin G antibody, as measured by an enzyme-linked immunosorbent assay (ELISA). Pertinent clinical and immunologic information was recorded. Univariate and multivariate analyses were performed to identify possible risk factors for measles seronegativity. MAIN OUTCOME MEASURE: Measles seronegativity, as defined by a lack of detectable antibody (ELISA predicted index value < 1.0). RESULTS: Thirteen (5%) patients lacked serologic evidence of immunity. Risk factors for measles seronegativity included year of birth in 1957 or later, Caucasian (non-Hispanic) race and oral hairy leukoplakia. Factors associated with progressive HIV disease (other than hairy leukoplakia) were not associated with a lack of existing immunity. CONCLUSIONS: A high prevalence (95%) of measles antibody was found in this large group of HIV-infected adults. Young, white individuals born in 1957 or later were at the greatest risk for measles seronegativity, but declining immunity due to progressive HIV infection did not appear to be associated with a lack of antibody. Self-reported histories of measles infection or immunization were not reliable predictors of measles immunity.
Keywords: Adolescence Adult Aged Antibodies, Viral/*BLOOD AIDS-Related Opportunistic Infections/COMPLICATIONS/IMMUNOLOGY Female Human HIV Infections/COMPLICATIONS/*IMMUNOLOGY *HIV-1 IgG/BLOOD Immunization Male Measles/COMPLICATIONS/IMMUNOLOGY/PREVENTION & CONTROL Measles Virus/*IMMUNOLOGY Middle Age Support, Non-U.S. Gov't JOURNAL ARTICLEKWDadolescenceadultagedantibodies,viral/KWDbloodaids-relatedopportunisticinfections/complications/immunologyfemalehumanhivinfections/complications/KWDimmunologyKWDhiv-1igg/bloodimmunizationmalemeasles/complications/immunology/prevention&controlmeaslesvirus/KWDimmunologymiddleagesupport,non-uKWDsKWDgov'tjournalarticle
930430
M9340800

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .